| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
355,637 |
314,455 |
$38.41M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
180,908 |
165,764 |
$18.27M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
143,014 |
126,499 |
$14.91M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
100,861 |
92,492 |
$10.92M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
85,830 |
80,332 |
$8.47M |
| 80053 |
Comprehensive metabolic panel |
65,160 |
51,972 |
$5.75M |
| D0120 |
Periodic oral evaluation - established patient |
59,735 |
56,417 |
$5.60M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
38,930 |
33,872 |
$5.41M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
43,169 |
39,573 |
$4.39M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
80,499 |
38,264 |
$4.35M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
23,508 |
22,245 |
$3.62M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
4,930 |
4,066 |
$3.40M |
| 99215 |
Prolong outpt/office vis |
37,851 |
32,025 |
$3.40M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
5,074 |
4,491 |
$3.29M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
4,113 |
3,930 |
$3.08M |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
65,316 |
30,513 |
$2.79M |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
19,264 |
4,634 |
$2.77M |
| G0378 |
Hospital observation service, per hour |
15,551 |
13,921 |
$2.60M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19,144 |
15,524 |
$2.58M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
10,700 |
10,021 |
$2.38M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
36,292 |
33,463 |
$2.37M |
| 92567 |
|
36,231 |
33,963 |
$1.98M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,224 |
9,086 |
$1.97M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25,551 |
18,372 |
$1.88M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
2,141 |
1,974 |
$1.86M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,721 |
5,355 |
$1.84M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
11,189 |
10,294 |
$1.78M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20,091 |
18,373 |
$1.69M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33,887 |
18,013 |
$1.67M |
| D1120 |
Prophylaxis - child |
51,472 |
48,556 |
$1.65M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
3,381 |
3,228 |
$1.62M |
| 93320 |
|
10,789 |
10,043 |
$1.59M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
88,941 |
73,458 |
$1.52M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
29,172 |
13,530 |
$1.39M |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
6,851 |
5,230 |
$1.37M |
| D1206 |
Topical application of fluoride varnish |
67,166 |
63,221 |
$1.28M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
3,861 |
3,702 |
$1.22M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,044 |
4,711 |
$1.17M |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
1,490 |
1,182 |
$1.15M |
| 93325 |
|
17,754 |
16,328 |
$1.13M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15,370 |
12,695 |
$1.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,643 |
6,198 |
$1.08M |
| 36430 |
|
5,154 |
3,997 |
$1.07M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
16,889 |
16,078 |
$1.05M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,633 |
12,125 |
$1.04M |
| D8670 |
Periodic orthodontic treatment visit |
4,969 |
4,382 |
$1.04M |
| 96040 |
|
8,142 |
7,523 |
$1.01M |
| 90834 |
Psychotherapy, 45 minutes with patient |
10,321 |
7,065 |
$983K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
4,988 |
3,455 |
$962K |
| D7140 |
Extraction, erupted tooth or exposed root |
7,526 |
3,665 |
$955K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
20,894 |
19,009 |
$920K |
| 64643 |
|
3,226 |
3,149 |
$909K |
| 95782 |
|
2,632 |
2,486 |
$888K |
| 81229 |
|
1,582 |
1,491 |
$887K |
| 76775 |
|
10,431 |
9,802 |
$873K |
| 86900 |
|
9,123 |
7,476 |
$866K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
4,057 |
3,778 |
$860K |
| 93321 |
|
5,501 |
5,090 |
$860K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,530 |
6,155 |
$857K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,542 |
2,858 |
$843K |
| D1351 |
Sealant - per tooth |
20,752 |
8,793 |
$837K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
3,919 |
3,774 |
$819K |
| 92579 |
|
16,267 |
15,312 |
$817K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16,568 |
12,308 |
$795K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,722 |
4,777 |
$776K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13,064 |
11,867 |
$756K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
6,326 |
5,834 |
$751K |
| 87070 |
|
13,524 |
11,030 |
$749K |
| 93308 |
|
3,594 |
3,293 |
$746K |
| 86003 |
|
49,661 |
5,481 |
$738K |
| 82728 |
|
26,582 |
23,601 |
$722K |
| 93356 |
|
3,995 |
3,760 |
$685K |
| D9920 |
|
3,272 |
3,125 |
$671K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28,359 |
25,796 |
$668K |
| 42830 |
|
968 |
925 |
$668K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16,770 |
12,283 |
$630K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
4,996 |
4,677 |
$625K |
| 84443 |
Thyroid stimulating hormone (TSH) |
31,186 |
28,359 |
$610K |
| 80061 |
Lipid panel |
17,897 |
16,389 |
$608K |
| 11900 |
|
5,195 |
4,902 |
$606K |
| 82803 |
|
8,155 |
7,406 |
$596K |
| 96367 |
|
5,211 |
4,079 |
$586K |
| 92587 |
|
9,279 |
8,823 |
$564K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,472 |
5,222 |
$553K |
| 84439 |
|
18,957 |
17,154 |
$552K |
| 95819 |
|
3,410 |
3,240 |
$546K |
| 92523 |
|
5,604 |
5,282 |
$540K |
| 64642 |
|
3,704 |
3,609 |
$518K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
2,975 |
2,665 |
$498K |
| 81003 |
|
23,638 |
20,346 |
$491K |
| D1110 |
Prophylaxis - adult |
12,924 |
12,278 |
$491K |
| 81025 |
|
18,176 |
16,334 |
$468K |
| 44970 |
|
318 |
297 |
$466K |
| 93304 |
|
2,032 |
1,915 |
$454K |
| D0272 |
Bitewings - two radiographic images |
30,647 |
28,744 |
$451K |
| 80197 |
|
9,770 |
5,302 |
$447K |
| 83021 |
|
7,737 |
6,859 |
$445K |
| 87077 |
|
25,693 |
15,853 |
$443K |
| 17110 |
|
4,249 |
4,016 |
$430K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,351 |
3,953 |
$426K |
| 71046 |
Radiologic examination, chest; 2 views |
27,215 |
24,818 |
$423K |
| 29075 |
|
4,737 |
4,228 |
$406K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,661 |
4,163 |
$404K |
| 94010 |
|
22,798 |
20,676 |
$396K |
| 92555 |
|
8,006 |
7,569 |
$389K |
| 82247 |
|
9,527 |
6,234 |
$373K |
| 97162 |
|
6,464 |
6,213 |
$373K |
| 93976 |
|
5,761 |
5,252 |
$369K |
| 96910 |
|
4,445 |
937 |
$366K |
| 96415 |
|
2,055 |
1,587 |
$365K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
22,331 |
19,695 |
$362K |
| 97161 |
|
6,080 |
5,850 |
$353K |
| 82962 |
|
15,129 |
9,354 |
$352K |
| 95700 |
|
2,224 |
1,987 |
$350K |
| 92557 |
|
3,090 |
2,946 |
$345K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,265 |
3,942 |
$344K |
| 95874 |
|
3,076 |
2,994 |
$344K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,260 |
2,082 |
$344K |
| 12011 |
|
3,085 |
2,933 |
$339K |
| 83655 |
|
10,611 |
9,891 |
$335K |
| 92504 |
|
9,787 |
8,991 |
$320K |
| 92610 |
|
5,005 |
4,675 |
$313K |
| 95816 |
|
1,688 |
1,608 |
$310K |
| 97116 |
|
10,382 |
5,864 |
$302K |
| 95117 |
|
6,147 |
3,390 |
$295K |
| 29065 |
|
3,214 |
2,873 |
$292K |
| 74018 |
|
11,819 |
10,554 |
$291K |
| 87799 |
|
6,708 |
3,543 |
$290K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
989 |
922 |
$289K |
| 85027 |
|
31,949 |
25,970 |
$288K |
| 99170 |
|
1,923 |
1,720 |
$287K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,895 |
1,724 |
$287K |
| 93225 |
|
2,878 |
2,704 |
$284K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,475 |
5,891 |
$284K |
| 92588 |
|
6,686 |
6,335 |
$282K |
| 82657 |
|
5,932 |
2,903 |
$280K |
| 20670 |
|
475 |
440 |
$279K |
| 92552 |
|
5,181 |
4,884 |
$277K |
| 29405 |
|
4,180 |
2,174 |
$276K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,369 |
2,219 |
$272K |
| 92526 |
|
5,602 |
4,058 |
$270K |
| 85007 |
|
15,763 |
11,702 |
$270K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,888 |
10,388 |
$267K |
| 82784 |
|
14,997 |
10,361 |
$264K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
6,522 |
3,400 |
$259K |
| D9230 |
Inhalation of nitrous oxide / analgesia, anxiolysis |
7,960 |
7,316 |
$254K |
| 81001 |
|
22,927 |
20,596 |
$254K |
| 92582 |
|
7,359 |
6,940 |
$251K |
| 74230 |
|
1,616 |
1,529 |
$250K |
| 70543 |
|
929 |
868 |
$248K |
| 72141 |
|
1,819 |
1,702 |
$247K |
| 12001 |
|
2,039 |
1,940 |
$238K |
| 85610 |
|
14,573 |
11,968 |
$233K |
| 49452 |
|
716 |
667 |
$228K |
| 96450 |
|
1,374 |
1,078 |
$227K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,513 |
3,107 |
$226K |
| 84450 |
|
15,967 |
14,509 |
$222K |
| D0140 |
Limited oral evaluation - problem focused |
1,429 |
1,356 |
$220K |
| 31575 |
|
2,173 |
2,036 |
$216K |
| 86140 |
|
18,081 |
15,571 |
$211K |
| 80164 |
|
2,959 |
2,650 |
$207K |
| 86832 |
|
1,593 |
1,447 |
$204K |
| 83880 |
|
5,069 |
4,420 |
$203K |
| 92556 |
|
4,456 |
4,229 |
$201K |
| 81415 |
|
245 |
211 |
$201K |
| 87506 |
|
986 |
890 |
$200K |
| 94644 |
|
7,116 |
6,567 |
$200K |
| 90686 |
|
18,104 |
16,936 |
$199K |
| 31622 |
|
325 |
313 |
$195K |
| 24538 |
|
103 |
97 |
$195K |
| 87497 |
|
4,553 |
2,836 |
$191K |
| 76536 |
|
2,609 |
2,474 |
$188K |
| V5020 |
Conformity evaluation |
1,741 |
1,664 |
$187K |
| 86833 |
|
1,594 |
1,449 |
$185K |
| D0330 |
Panoramic radiographic image |
3,321 |
3,216 |
$182K |
| 82330 |
|
4,878 |
3,955 |
$181K |
| 72082 |
|
7,240 |
6,808 |
$178K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,788 |
1,684 |
$175K |
| D0220 |
Intraoral - periapical first radiographic image |
10,854 |
9,980 |
$174K |
| 87088 |
|
7,166 |
6,367 |
$174K |
| 97535 |
Self-care/home management training, each 15 minutes |
8,250 |
5,170 |
$170K |
| 76885 |
|
1,898 |
1,764 |
$167K |
| 43762 |
|
3,068 |
2,849 |
$166K |
| 85576 |
|
2,776 |
1,833 |
$166K |
| 89051 |
|
2,313 |
1,849 |
$166K |
| 97166 |
|
2,970 |
2,851 |
$165K |
| 86920 |
|
8,969 |
4,743 |
$164K |
| 70486 |
|
1,717 |
1,605 |
$159K |
| 72146 |
|
1,554 |
1,460 |
$159K |
| 74240 |
|
1,852 |
1,734 |
$154K |
| 96156 |
|
2,724 |
2,287 |
$151K |
| 80051 |
|
2,263 |
1,657 |
$151K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,751 |
17,711 |
$150K |
| 92611 |
|
1,414 |
1,344 |
$149K |
| G0379 |
Direct admission of patient for hospital observation care |
2,670 |
2,378 |
$147K |
| 87507 |
|
417 |
381 |
$147K |
| D0240 |
|
12,849 |
7,075 |
$146K |
| 76870 |
|
2,102 |
1,952 |
$146K |
| 95951 |
|
766 |
545 |
$146K |
| 81479 |
Unlisted molecular pathology procedure |
2,090 |
1,503 |
$145K |
| 83986 |
|
1,846 |
1,351 |
$145K |
| 73610 |
|
9,698 |
8,105 |
$140K |
| 82565 |
|
7,851 |
6,398 |
$138K |
| 73630 |
|
10,849 |
8,882 |
$137K |
| 87186 |
|
14,458 |
10,851 |
$133K |
| 85397 |
|
4,175 |
3,683 |
$130K |
| 83970 |
|
3,077 |
2,762 |
$130K |
| 92015 |
Determination of refractive state |
33,283 |
31,859 |
$127K |
| 95712 |
|
936 |
853 |
$127K |
| 96136 |
|
1,108 |
954 |
$121K |
| 97165 |
|
2,137 |
2,040 |
$120K |
| 86902 |
|
7,495 |
3,210 |
$120K |
| 84460 |
|
19,425 |
17,379 |
$119K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,971 |
1,839 |
$118K |
| 85246 |
|
4,057 |
3,702 |
$116K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,194 |
3,408 |
$116K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,640 |
3,198 |
$115K |
| 92553 |
|
1,488 |
1,419 |
$114K |
| 92585 |
|
981 |
914 |
$114K |
| 83735 |
|
15,223 |
10,341 |
$113K |
| 83550 |
|
12,008 |
10,839 |
$113K |
| 16020 |
|
1,780 |
1,269 |
$109K |
| 82397 |
|
2,508 |
2,253 |
$108K |
| J2545 |
Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg |
752 |
677 |
$106K |
| 95715 |
|
451 |
392 |
$105K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
733 |
671 |
$104K |
| 10060 |
|
1,121 |
1,035 |
$103K |
| 72170 |
|
6,994 |
6,513 |
$101K |
| 24640 |
|
483 |
464 |
$101K |
| 83540 |
|
12,335 |
11,109 |
$100K |
| 73140 |
|
6,663 |
5,647 |
$100K |
| 87040 |
|
6,187 |
5,184 |
$99K |
| 76770 |
|
968 |
914 |
$99K |
| 82785 |
|
2,382 |
2,069 |
$96K |
| 82150 |
|
3,580 |
3,251 |
$95K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15,980 |
8,917 |
$95K |
| 83520 |
|
2,551 |
2,243 |
$94K |
| 85045 |
|
20,097 |
15,035 |
$93K |
| 94660 |
|
329 |
289 |
$93K |
| 96158 |
|
3,903 |
2,738 |
$93K |
| 29345 |
|
897 |
791 |
$93K |
| 96132 |
|
1,183 |
925 |
$92K |
| 82570 |
|
6,847 |
5,764 |
$92K |
| 96112 |
|
2,151 |
1,709 |
$91K |
| 82043 |
|
2,895 |
2,564 |
$91K |
| 83002 |
|
2,853 |
2,524 |
$91K |
| 92586 |
|
630 |
595 |
$89K |
| 86592 |
|
3,488 |
3,203 |
$88K |
| 94645 |
|
3,929 |
3,664 |
$88K |
| 84403 |
|
3,192 |
2,789 |
$87K |
| 87529 |
|
2,234 |
950 |
$85K |
| 83516 |
|
6,053 |
4,795 |
$84K |
| 84100 |
|
15,941 |
11,150 |
$81K |
| 92524 |
|
1,864 |
1,740 |
$81K |
| 80076 |
|
2,228 |
2,010 |
$81K |
| 76000 |
|
4,566 |
4,088 |
$80K |
| D0274 |
Bitewings - four radiographic images |
4,662 |
4,476 |
$78K |
| 77072 |
|
3,150 |
2,906 |
$77K |
| 80195 |
|
1,874 |
1,222 |
$77K |
| 80177 |
|
486 |
443 |
$76K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
251 |
197 |
$75K |
| 82310 |
|
1,777 |
1,456 |
$75K |
| 86481 |
|
839 |
771 |
$74K |
| 25605 |
|
344 |
320 |
$73K |
| 83690 |
|
6,970 |
6,223 |
$73K |
| 83615 |
|
8,445 |
5,626 |
$72K |
| 83993 |
|
1,368 |
1,182 |
$71K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,979 |
2,727 |
$71K |
| 92593 |
|
1,158 |
1,112 |
$70K |
| 84305 |
|
2,697 |
2,464 |
$69K |
| 73110 |
|
3,888 |
3,367 |
$68K |
| 73090 |
|
8,888 |
6,715 |
$68K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,635 |
9,296 |
$67K |
| 96137 |
|
523 |
481 |
$67K |
| 96133 |
|
955 |
753 |
$67K |
| 73590 |
|
8,052 |
6,054 |
$67K |
| 96139 |
|
1,030 |
813 |
$66K |
| 96138 |
|
1,085 |
861 |
$65K |
| 74183 |
|
321 |
292 |
$65K |
| 87101 |
|
2,726 |
2,387 |
$65K |
| 73130 |
|
5,868 |
5,044 |
$64K |
| 73552 |
|
4,516 |
3,447 |
$63K |
| 92060 |
|
15,259 |
14,645 |
$63K |
| 12051 |
|
480 |
453 |
$62K |
| D1354 |
|
2,674 |
1,514 |
$62K |
| 82139 |
|
726 |
630 |
$61K |
| 82947 |
|
7,546 |
6,662 |
$61K |
| 70360 |
|
4,036 |
3,800 |
$61K |
| 75561 |
|
330 |
302 |
$61K |
| 83001 |
|
2,653 |
2,369 |
$61K |
| 76377 |
|
1,409 |
1,294 |
$60K |
| 49465 |
|
204 |
175 |
$60K |
| 85730 |
|
8,890 |
7,748 |
$60K |
| D2393 |
Resin-based composite - three surfaces, posterior, primary or permanent |
714 |
464 |
$59K |
| 82550 |
|
4,405 |
3,671 |
$59K |
| 77080 |
|
945 |
872 |
$58K |
| 85652 |
|
17,460 |
15,393 |
$58K |
| 73560 |
|
6,435 |
5,150 |
$58K |
| 96152 |
|
1,400 |
990 |
$57K |
| 82105 |
|
1,756 |
1,510 |
$57K |
| 72156 |
|
280 |
256 |
$56K |
| 88185 |
|
3,864 |
1,617 |
$54K |
| 76881 |
|
707 |
606 |
$54K |
| 87205 |
|
12,949 |
10,543 |
$54K |
| 75565 |
|
632 |
590 |
$54K |
| 82670 |
|
1,466 |
1,319 |
$53K |
| 86803 |
|
3,101 |
2,762 |
$52K |
| 82977 |
|
6,286 |
5,174 |
$52K |
| 87081 |
|
3,577 |
2,990 |
$52K |
| 76882 |
|
1,084 |
986 |
$52K |
| 73070 |
|
8,015 |
5,675 |
$51K |
| 72158 |
|
269 |
246 |
$51K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
39,311 |
35,673 |
$50K |
| 76825 |
|
1,224 |
1,034 |
$50K |
| 80143 |
|
2,185 |
1,812 |
$50K |
| 51600 |
|
706 |
669 |
$50K |
| 86850 |
|
8,538 |
6,929 |
$49K |
| 86160 |
|
3,587 |
1,668 |
$49K |
| 82040 |
|
1,681 |
1,467 |
$49K |
| 83498 |
|
1,700 |
1,528 |
$48K |
| 86364 |
|
4,723 |
4,186 |
$48K |
| 82248 |
|
5,511 |
4,357 |
$48K |
| 99157 |
|
9,908 |
9,198 |
$48K |
| 87210 |
|
2,455 |
2,208 |
$48K |
| 86945 |
|
7,463 |
3,942 |
$48K |
| 96376 |
|
5,231 |
3,552 |
$47K |
| 82607 |
|
2,040 |
1,874 |
$47K |
| 93226 |
|
2,889 |
2,706 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,971 |
8,458 |
$47K |
| 72157 |
|
245 |
221 |
$47K |
| 72081 |
|
6,687 |
6,207 |
$46K |
| 94642 |
|
718 |
635 |
$46K |
| 86376 |
|
2,938 |
2,593 |
$45K |
| 97163 |
|
807 |
771 |
$44K |
| 84145 |
|
1,125 |
1,004 |
$44K |
| 82533 |
|
1,512 |
1,196 |
$44K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,196 |
1,082 |
$44K |
| 43760 |
|
356 |
335 |
$44K |
| 74019 |
|
4,475 |
4,079 |
$43K |
| 84484 |
|
3,260 |
2,740 |
$43K |
| 85240 |
|
2,802 |
2,503 |
$43K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
505 |
283 |
$43K |
| 29105 |
|
1,211 |
1,105 |
$42K |
| 29450 |
|
294 |
124 |
$42K |
| 94060 |
|
2,668 |
2,447 |
$41K |
| 70544 |
|
164 |
151 |
$41K |
| 69210 |
|
2,597 |
2,475 |
$40K |
| 96130 |
|
291 |
260 |
$40K |
| 90791 |
Psychiatric diagnostic evaluation |
695 |
571 |
$40K |
| 77076 |
|
1,236 |
1,082 |
$39K |
| 84402 |
|
1,443 |
1,290 |
$39K |
| 73562 |
|
1,904 |
1,600 |
$38K |
| 92652 |
|
1,139 |
1,077 |
$38K |
| 97803 |
|
13,056 |
11,653 |
$38K |
| 80299 |
|
602 |
499 |
$37K |
| 0001A |
|
1,302 |
1,067 |
$37K |
| 96116 |
|
524 |
375 |
$36K |
| 82627 |
|
1,141 |
1,029 |
$36K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
830 |
779 |
$36K |
| D9420 |
|
350 |
268 |
$35K |
| 87631 |
|
267 |
230 |
$35K |
| 51701 |
|
6,073 |
5,663 |
$35K |
| 51741 |
|
416 |
392 |
$35K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
520 |
312 |
$35K |
| 86038 |
|
2,522 |
2,202 |
$35K |
| 82017 |
|
531 |
470 |
$35K |
| 92592 |
|
537 |
512 |
$35K |
| 81002 |
|
1,457 |
1,317 |
$34K |
| 92595 |
|
329 |
307 |
$34K |
| 90832 |
Psychotherapy, 30 minutes with patient |
661 |
482 |
$34K |
| 86706 |
|
2,684 |
2,418 |
$33K |
| 90656 |
|
3,261 |
3,049 |
$32K |
| 74455 |
|
465 |
440 |
$32K |
| J2515 |
Injection, pentobarbital sodium, per 50 mg |
1,105 |
1,018 |
$32K |
| 87185 |
|
360 |
310 |
$32K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
271 |
248 |
$32K |
| 84295 |
|
3,273 |
2,822 |
$31K |
| 49446 |
|
78 |
69 |
$31K |
| 29125 |
|
1,007 |
923 |
$31K |
| 20680 |
|
35 |
32 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
537 |
503 |
$31K |
| 86901 |
|
9,094 |
7,463 |
$31K |
| 87808 |
|
2,218 |
2,003 |
$31K |
| 86355 |
|
913 |
787 |
$31K |
| 82272 |
|
1,234 |
1,120 |
$31K |
| 85014 |
|
4,124 |
3,575 |
$30K |
| 94621 |
|
379 |
350 |
$30K |
| 92602 |
|
153 |
140 |
$29K |
| 72100 |
|
2,262 |
2,130 |
$29K |
| 80179 |
|
2,005 |
1,725 |
$29K |
| 87340 |
|
2,572 |
2,298 |
$29K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
24,524 |
17,462 |
$29K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
29,891 |
23,475 |
$29K |
| 83525 |
|
2,309 |
2,106 |
$29K |
| 94770 |
|
172 |
155 |
$29K |
| 87806 |
|
1,159 |
1,059 |
$29K |
| 86039 |
|
2,522 |
2,202 |
$29K |
| 84146 |
|
1,226 |
1,098 |
$29K |
| D1208 |
Topical application of fluoride, excluding varnish |
736 |
664 |
$28K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
42,420 |
36,491 |
$28K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
108 |
96 |
$28K |
| 70491 |
|
162 |
149 |
$28K |
| 73660 |
|
1,615 |
1,406 |
$27K |
| 96113 |
|
1,113 |
876 |
$27K |
| 70250 |
|
990 |
905 |
$27K |
| 86665 |
|
1,594 |
725 |
$27K |
| 85378 |
|
2,286 |
1,857 |
$27K |
| 72040 |
|
2,945 |
2,595 |
$27K |
| 88184 |
|
2,041 |
1,638 |
$26K |
| 99001 |
|
982 |
866 |
$26K |
| 71555 |
|
145 |
134 |
$26K |
| 73000 |
|
2,455 |
2,079 |
$26K |
| 92551 |
|
253 |
230 |
$26K |
| 87581 |
|
647 |
576 |
$26K |
| 0002A |
|
818 |
720 |
$26K |
| 86704 |
|
1,685 |
1,482 |
$25K |
| 80184 |
|
295 |
258 |
$25K |
| 84132 |
|
3,769 |
3,232 |
$25K |
| 86225 |
|
1,698 |
1,480 |
$25K |
| 69200 |
|
1,232 |
1,063 |
$25K |
| 96131 |
|
234 |
204 |
$25K |
| J3590 |
Unclassified biologics |
652 |
444 |
$24K |
| 85384 |
|
2,328 |
1,886 |
$24K |
| 73060 |
|
2,437 |
1,987 |
$24K |
| 90734 |
|
772 |
669 |
$24K |
| 90651 |
|
564 |
474 |
$23K |
| J2704 |
Injection, propofol, 10 mg |
40,395 |
35,338 |
$23K |
| 85250 |
|
951 |
852 |
$23K |
| 73100 |
|
7,258 |
5,241 |
$23K |
| 86800 |
|
1,445 |
1,292 |
$23K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
856 |
639 |
$22K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,002 |
475 |
$22K |
| 87046 |
|
1,259 |
1,141 |
$22K |
| 84520 |
|
4,835 |
4,128 |
$22K |
| 85660 |
|
2,853 |
1,851 |
$21K |
| 87206 |
|
3,534 |
2,945 |
$21K |
| 93017 |
|
247 |
224 |
$21K |
| 42821 |
|
26 |
24 |
$20K |
| 71250 |
|
266 |
246 |
$20K |
| 93886 |
|
150 |
128 |
$20K |
| 87493 |
|
486 |
435 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
4,344 |
3,756 |
$20K |
| 92522 |
|
641 |
597 |
$20K |
| 87209 |
|
802 |
697 |
$20K |
| 77073 |
|
2,729 |
2,515 |
$20K |
| 49580 |
|
25 |
24 |
$19K |
| 99195 |
|
1,946 |
1,675 |
$19K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27,252 |
23,517 |
$18K |
| J0588 |
Injection, incobotulinumtoxin a, 1 unit |
87 |
86 |
$18K |
| 64999 |
|
114 |
43 |
$18K |
| 76010 |
|
1,352 |
1,249 |
$18K |
| 96409 |
|
2,567 |
1,838 |
$18K |
| 90837 |
Psychotherapy, 53 minutes with patient |
194 |
130 |
$18K |
| 87632 |
|
87 |
83 |
$18K |
| 92604 |
|
246 |
231 |
$18K |
| 73030 |
|
2,382 |
2,039 |
$18K |
| 84478 |
|
2,417 |
2,053 |
$18K |
| 72070 |
|
1,650 |
1,540 |
$17K |
| 87103 |
|
700 |
583 |
$17K |
| 90715 |
|
1,598 |
1,464 |
$17K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
23,245 |
20,347 |
$17K |
| 88307 |
|
922 |
817 |
$17K |
| 76827 |
|
1,226 |
1,034 |
$17K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
13,609 |
12,526 |
$17K |
| 73564 |
|
2,198 |
1,701 |
$17K |
| 90670 |
|
579 |
487 |
$16K |
| 87107 |
|
329 |
274 |
$16K |
| J3490 |
Unclassified drugs |
15,558 |
11,768 |
$16K |
| 86359 |
|
591 |
503 |
$16K |
| 86308 |
|
902 |
839 |
$16K |
| 99155 |
|
6,194 |
5,704 |
$16K |
| 17250 |
|
139 |
121 |
$16K |
| 82610 |
|
819 |
736 |
$15K |
| 88304 |
|
2,481 |
2,208 |
$15K |
| 86235 |
|
386 |
180 |
$15K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
94 |
93 |
$15K |
| 54640 |
|
12 |
12 |
$15K |
| 84156 |
|
3,244 |
2,622 |
$15K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
569 |
530 |
$14K |
| 87177 |
|
803 |
698 |
$14K |
| 73502 |
|
575 |
474 |
$14K |
| 82805 |
|
234 |
162 |
$14K |
| 80175 |
|
192 |
185 |
$14K |
| 96159 |
|
2,130 |
1,515 |
$14K |
| 25565 |
|
80 |
73 |
$13K |
| 29130 |
|
190 |
184 |
$13K |
| 87272 |
|
1,058 |
920 |
$13K |
| 80183 |
|
349 |
335 |
$13K |
| 82140 |
|
556 |
467 |
$13K |
| 87338 |
|
487 |
439 |
$13K |
| 86664 |
|
762 |
697 |
$13K |
| D7111 |
|
27 |
25 |
$13K |
| D0230 |
Intraoral - periapical each additional radiographic image |
2,044 |
1,805 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
104,484 |
87,983 |
$13K |
| 86769 |
|
336 |
314 |
$13K |
| 95713 |
|
177 |
147 |
$13K |
| 85018 |
|
2,226 |
2,008 |
$13K |
| 84202 |
|
713 |
621 |
$12K |
| 92134 |
|
306 |
293 |
$12K |
| 86618 |
|
540 |
368 |
$12K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
8,383 |
7,691 |
$12K |
| 97802 |
|
2,007 |
1,746 |
$12K |
| 84590 |
|
998 |
837 |
$12K |
| 84446 |
|
915 |
770 |
$11K |
| 97167 |
|
213 |
205 |
$11K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
2,693 |
2,510 |
$11K |
| 77075 |
|
271 |
240 |
$11K |
| 51784 |
|
103 |
97 |
$11K |
| 87486 |
|
272 |
209 |
$11K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
1,383 |
936 |
$11K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12,180 |
11,077 |
$10K |
| 86317 |
|
243 |
79 |
$10K |
| 92609 |
|
182 |
126 |
$10K |
| 92594 |
|
77 |
74 |
$10K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,220 |
1,152 |
$10K |
| 70480 |
|
92 |
89 |
$10K |
| 84480 |
|
652 |
584 |
$10K |
| 82104 |
|
448 |
372 |
$9K |
| 82390 |
|
721 |
608 |
$9K |
| 86644 |
|
344 |
272 |
$8K |
| 84550 |
|
1,640 |
1,196 |
$8K |
| 69209 |
|
442 |
414 |
$8K |
| J3480 |
Injection, potassium chloride, per 2 meq |
4,874 |
3,570 |
$8K |
| 96150 |
|
124 |
116 |
$8K |
| 87533 |
|
273 |
112 |
$8K |
| 99153 |
Mod sedat endo service >5yrs |
1,303 |
1,193 |
$8K |
| 86341 |
|
312 |
142 |
$8K |
| 86480 |
|
90 |
82 |
$8K |
| 88271 |
|
373 |
141 |
$7K |
| 82525 |
|
273 |
247 |
$7K |
| 83605 |
|
526 |
433 |
$7K |
| 87634 |
|
116 |
103 |
$7K |
| 92650 |
|
455 |
428 |
$7K |
| 86922 |
|
387 |
166 |
$7K |
| 86357 |
|
225 |
197 |
$7K |
| 99156 |
|
4,820 |
4,510 |
$7K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12,548 |
11,284 |
$7K |
| 92591 |
|
226 |
220 |
$7K |
| J0475 |
Injection, baclofen, 10 mg |
26 |
26 |
$7K |
| 62270 |
|
28 |
26 |
$6K |
| 73592 |
|
621 |
376 |
$6K |
| 81267 |
|
58 |
28 |
$6K |
| 96368 |
|
43 |
42 |
$6K |
| 96167 |
|
876 |
685 |
$6K |
| 90648 |
|
544 |
468 |
$6K |
| 90633 |
|
447 |
362 |
$6K |
| 11100 |
|
25 |
24 |
$6K |
| 92018 |
|
15 |
14 |
$6K |
| 84630 |
|
585 |
533 |
$6K |
| 12002 |
|
63 |
55 |
$6K |
| 74220 |
|
153 |
139 |
$6K |
| 82746 |
|
375 |
340 |
$6K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
3,984 |
2,904 |
$6K |
| 82379 |
|
299 |
269 |
$6K |
| 87498 |
|
130 |
115 |
$5K |
| 93975 |
|
64 |
61 |
$5K |
| 86880 |
|
728 |
579 |
$5K |
| 93786 |
|
159 |
151 |
$5K |
| 41010 |
|
16 |
13 |
$5K |
| 82542 |
|
102 |
82 |
$5K |
| 88342 |
|
1,733 |
1,453 |
$5K |
| 11901 |
|
54 |
52 |
$5K |
| 80201 |
|
189 |
176 |
$5K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
25,261 |
23,414 |
$5K |
| 97164 |
|
96 |
96 |
$5K |
| 72197 |
|
32 |
30 |
$5K |
| 84703 |
|
220 |
202 |
$5K |
| 92250 |
|
1,140 |
1,070 |
$5K |
| 80158 |
|
65 |
37 |
$5K |
| 29505 |
|
105 |
101 |
$5K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
172 |
147 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,483 |
3,024 |
$4K |
| V5264 |
Ear mold/insert, not disposable, any type |
3,678 |
3,143 |
$4K |
| 93242 |
|
55 |
54 |
$4K |
| 76642 |
|
56 |
49 |
$4K |
| 36591 |
|
394 |
302 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,284 |
5,455 |
$4K |
| 83921 |
|
159 |
136 |
$4K |
| 90620 |
|
84 |
83 |
$4K |
| P9035 |
Platelets, pheresis, leukocytes reduced, each unit |
18 |
12 |
$4K |
| 84436 |
|
57 |
54 |
$4K |
| 85245 |
|
103 |
96 |
$4K |
| 99151 |
|
764 |
696 |
$4K |
| 83789 |
|
156 |
145 |
$4K |
| 51728 |
|
31 |
28 |
$3K |
| D0210 |
Intraoral - complete series of radiographic images |
47 |
45 |
$3K |
| 86015 |
|
333 |
290 |
$3K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,842 |
925 |
$3K |
| 30300 |
|
100 |
93 |
$3K |
| 36416 |
|
6,471 |
5,066 |
$3K |
| J9070 |
Cyclophosphamide, 100 mg |
18 |
12 |
$3K |
| 76506 |
|
32 |
26 |
$3K |
| 83918 |
|
68 |
60 |
$3K |
| 12032 |
|
31 |
26 |
$3K |
| 74181 |
|
15 |
15 |
$3K |
| 84075 |
|
389 |
346 |
$3K |
| 88313 |
|
2,257 |
1,355 |
$3K |
| 11104 |
|
15 |
12 |
$3K |
| 86684 |
|
214 |
176 |
$3K |
| 29515 |
|
269 |
250 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,904 |
1,602 |
$3K |
| 42975 |
|
130 |
125 |
$3K |
| 0296T |
|
23 |
21 |
$3K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
18,332 |
16,766 |
$3K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,209 |
1,077 |
$3K |
| 82652 |
|
38 |
28 |
$2K |
| 87536 |
|
33 |
27 |
$2K |
| 90700 |
|
193 |
173 |
$2K |
| 85347 |
|
316 |
162 |
$2K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
11,783 |
10,723 |
$2K |
| 81243 |
|
15 |
14 |
$2K |
| 85247 |
|
71 |
68 |
$2K |
| 99188 |
|
3,375 |
2,600 |
$2K |
| J7070 |
Infusion, d5w, 1000 cc |
1,040 |
782 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,578 |
2,096 |
$2K |
| 94617 |
|
13 |
13 |
$2K |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
107 |
61 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,403 |
3,519 |
$2K |
| 82747 |
|
97 |
90 |
$2K |
| 92583 |
|
779 |
737 |
$2K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
64 |
55 |
$2K |
| 85670 |
|
2,863 |
2,410 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,803 |
1,581 |
$2K |
| 95250 |
|
129 |
110 |
$2K |
| 82157 |
|
31 |
25 |
$2K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,063 |
1,010 |
$2K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
10,300 |
8,950 |
$2K |
| 86645 |
|
223 |
197 |
$2K |
| 95076 |
|
14 |
13 |
$2K |
| J9370 |
Vincristine sulfate, 1 mg |
2,729 |
1,809 |
$2K |
| D0270 |
|
85 |
83 |
$2K |
| 0071A |
|
75 |
53 |
$2K |
| C1769 |
Guide wire |
2,822 |
2,565 |
$2K |
| 80050 |
General health panel |
556 |
498 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,076 |
1,943 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,984 |
1,786 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
50 |
47 |
$2K |
| 93243 |
|
55 |
54 |
$2K |
| 86787 |
|
120 |
106 |
$2K |
| 51798 |
|
250 |
241 |
$2K |
| 82085 |
|
51 |
38 |
$2K |
| 86337 |
|
86 |
67 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,320 |
1,172 |
$1K |
| 90723 |
|
329 |
281 |
$1K |
| 94726 |
|
350 |
324 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$1K |
| 84030 |
|
100 |
81 |
$1K |
| 92590 |
|
15 |
14 |
$1K |
| 0072A |
|
52 |
41 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,885 |
1,724 |
$1K |
| 11981 |
|
15 |
13 |
$1K |
| 73620 |
|
174 |
117 |
$1K |
| 81000 |
|
66 |
63 |
$1K |
| 82024 |
|
29 |
26 |
$1K |
| 87075 |
|
150 |
109 |
$1K |
| 82465 |
|
53 |
42 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
254 |
162 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
742 |
698 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,128 |
877 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
259 |
204 |
$997.54 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,046 |
7,215 |
$987.78 |
| 85732 |
|
103 |
93 |
$966.68 |
| D0340 |
|
36 |
29 |
$951.94 |
| 91200 |
|
795 |
727 |
$917.34 |
| 86008 |
|
26 |
18 |
$895.37 |
| V5241 |
Dispensing fee, monaural hearing aid, any type |
37 |
30 |
$851.12 |
| 76604 |
|
12 |
12 |
$813.35 |
| 86774 |
|
29 |
25 |
$794.39 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
6,186 |
5,694 |
$772.05 |
| 86709 |
|
54 |
50 |
$750.20 |
| 93971 |
|
26 |
24 |
$744.90 |
| 84481 |
|
26 |
26 |
$717.33 |
| 88280 |
|
26 |
24 |
$701.62 |
| 97168 |
|
14 |
13 |
$694.90 |
| 51797 |
|
13 |
12 |
$681.39 |
| 94761 |
|
1,343 |
963 |
$680.16 |
| 85280 |
|
27 |
24 |
$678.04 |
| 82261 |
|
41 |
39 |
$655.27 |
| 88291 |
|
43 |
43 |
$650.75 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
9,204 |
8,413 |
$645.88 |
| 76937 |
|
14 |
14 |
$641.49 |
| 90685 |
|
58 |
56 |
$637.95 |
| 87522 |
Neg quan hep c or qual rna |
13 |
12 |
$626.10 |
| 97804 |
|
131 |
124 |
$624.76 |
| 88312 |
|
601 |
420 |
$608.53 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
110 |
104 |
$570.81 |
| 73092 |
|
30 |
26 |
$566.33 |
| 86258 |
|
90 |
40 |
$538.15 |
| 73700 |
|
13 |
12 |
$533.00 |
| 82775 |
|
27 |
26 |
$527.99 |
| 98960 |
|
60 |
51 |
$525.81 |
| D0470 |
|
19 |
15 |
$524.81 |
| 83930 |
|
27 |
25 |
$455.22 |
| 83090 |
|
13 |
12 |
$436.90 |
| 95012 |
|
462 |
422 |
$428.94 |
| 76857 |
|
25 |
24 |
$428.89 |
| 95199 |
|
133 |
118 |
$426.92 |
| 96411 |
|
314 |
176 |
$418.94 |
| 83020 |
|
27 |
26 |
$418.49 |
| 92511 |
|
15 |
14 |
$408.83 |
| J7510 |
Prednisolone oral, per 5 mg |
2,111 |
1,568 |
$361.21 |
| 98961 |
|
17 |
14 |
$351.42 |
| 84445 |
|
13 |
12 |
$339.72 |
| 0124A |
|
16 |
13 |
$322.27 |
| 90677 |
|
109 |
92 |
$316.56 |
| 36592 |
|
34 |
24 |
$302.38 |
| 84510 |
|
27 |
26 |
$296.06 |
| 0297T |
|
23 |
21 |
$294.40 |
| 87184 |
|
44 |
38 |
$291.31 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
463 |
433 |
$277.32 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
358 |
333 |
$265.57 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
1,607 |
1,107 |
$263.29 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,969 |
3,162 |
$262.13 |
| 82945 |
|
64 |
59 |
$259.39 |
| 84210 |
|
13 |
12 |
$253.38 |
| 90732 |
|
28 |
24 |
$253.16 |
| 84157 |
|
64 |
59 |
$245.97 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
346 |
252 |
$237.55 |
| 73600 |
|
104 |
80 |
$226.05 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
633 |
604 |
$208.23 |
| J1940 |
Injection, furosemide, up to 20 mg |
93 |
85 |
$205.08 |
| 82438 |
|
26 |
24 |
$204.79 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
275 |
202 |
$198.51 |
| 92133 |
|
156 |
148 |
$192.55 |
| 85270 |
|
13 |
12 |
$191.86 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,047 |
916 |
$184.62 |
| 94760 |
|
272 |
258 |
$174.35 |
| 91300 |
|
2,116 |
1,619 |
$155.32 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
934 |
700 |
$154.81 |
| 86765 |
|
14 |
12 |
$146.41 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
241 |
172 |
$141.67 |
| J0706 |
Injection, caffeine citrate, 5 mg |
197 |
187 |
$140.08 |
| 90710 |
|
56 |
43 |
$138.97 |
| 89230 |
|
13 |
12 |
$127.18 |
| 86060 |
|
15 |
12 |
$117.18 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
292 |
236 |
$115.72 |
| J7699 |
Noc drugs, inhalation solution administered through dme |
1,477 |
1,287 |
$111.49 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
209 |
192 |
$109.43 |
| D0350 |
|
42 |
40 |
$99.63 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
100 |
78 |
$98.83 |
| 94664 |
|
171 |
166 |
$90.61 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
131 |
123 |
$84.08 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
35 |
28 |
$83.32 |
| 90674 |
|
13 |
13 |
$80.60 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
91 |
63 |
$78.82 |
| 86431 |
|
13 |
13 |
$71.98 |
| 73120 |
|
24 |
13 |
$66.60 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
671 |
443 |
$60.96 |
| 99152 |
|
162 |
155 |
$39.30 |
| J1644 |
Injection, heparin sodium, per 1000 units |
519 |
347 |
$33.90 |
| 88341 |
|
19 |
12 |
$28.51 |
| 70260 |
|
12 |
12 |
$21.17 |
| 36593 |
|
13 |
12 |
$20.52 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
145 |
107 |
$12.57 |
| 73080 |
|
28 |
26 |
$0.00 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
56 |
52 |
$0.00 |
| 94690 |
|
26 |
24 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
16 |
12 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
147 |
138 |
$0.00 |
| V5261 |
Hearing aid, digital, binaural, bte |
44 |
43 |
$0.00 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
79 |
54 |
$0.00 |
| 95018 |
|
14 |
13 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
47 |
25 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
42 |
32 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
28 |
26 |
$0.00 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
12 |
12 |
$0.00 |
| V5257 |
Hearing aid, digital, monaural, bte |
13 |
12 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
12 |
12 |
$0.00 |
| 96168 |
|
329 |
275 |
$0.00 |
| 91307 |
|
143 |
104 |
$0.00 |
| V5160 |
Dispensing fee, binaural |
60 |
59 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
2,920 |
2,569 |
$0.00 |
| D9997 |
|
441 |
425 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
46 |
44 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
123 |
105 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
313 |
266 |
$0.00 |
| Q0164 |
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
17 |
16 |
$0.00 |
| 88311 |
|
16 |
13 |
$0.00 |
| J3410 |
Injection, hydroxyzine hcl, up to 25 mg |
21 |
13 |
$0.00 |
| D9248 |
|
37 |
37 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
19 |
16 |
$0.00 |